Ascendis Pharma A/S

ASND

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001612042

SEC filings (opens in a new tab)

In the last 90 days, Ascendis Pharma A/S insiders filed 1 open-market purchase and 2 sales; 313 institutions reported holding it in 13F filings for Q2 2026, worth $17.8B in total; no superinvestor holds it.

Q4 2022 vs. Q3 2022

How the institutions holding Ascendis Pharma A/S changed between Q3 2022 and Q4 2022.

All holders in Q4 2022 All holders in Q3 2022

13F holders of ASND: Q3 2022 compared with Q4 2022
Measure	Q3 2022	Of which not filed for Q4 2022	Q4 2022	Change
Holders	183	3	187	+7
Shares	66.7M	134.7K	65.9M	−646.1K (−1.0%)
Value	$6.89B	$13.9M	$8.05B	+$1.17B (+17.1%)

3 institutions that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (30)

Institutions that held Ascendis Pharma A/S at the end of Q4 2022 but not at the end of Q3 2022.

Institutions new to ASND in Q4 2022
Institution	Shares	Value	% of portfolio
Summit Partners Public Asset Management, LLC	172,751	$21.1M	1.54%
Tri Locum Partners LP	99,215	$12.1M	5.36%
Saturn V Capital Management LLC	68,404	$7.95M	6.60%
Balyasny Asset Management LLC	53,497	$6.53M	0.02%
FIL Ltd	45,065	$5.50M	0.01%
Arrowstreet Capital, Limited Partnership	29,218	$3.57M	0.00%
Moore Capital Management, LP	20,000	$2.44M	0.07%
Fred Alger Management, LLC	14,556	$1.78M	0.01%
Captrust Financial Advisors	12,325	$1.51M	0.01%
Raymond James Financial Services Advisors, Inc.	5,467	$667.7K	0.00%
Engineers Gate Manager LP	5,368	$655.6K	0.04%
Hennion & Walsh Asset Management, Inc.	4,710	$575.0K	0.04%
Profund Advisors LLC	2,960	$361.5K	0.02%
Credit Suisse AG	2,779	$339.4K	0.00%
Legato Capital Management LLC	2,701	$329.9K	0.06%
Trexquant Investment LP	2,050	$250.4K	0.01%
SG3 Management, LLC	2,000	$244.3K	0.15%
LPL Financial LLC	1,736	$212.0K	0.00%
Simplex Trading, LLC	1,617	$197.0K	0.01%
Centiva Capital, LP	1,188	$145.1K	0.01%
Advisory Services Network, LLC	498	$60.8K	0.00%
Belpointe Asset Management LLC	373	$45.6K	0.00%
Cutler Group LP	200	$24.0K	0.00%
TCI Wealth Advisors, Inc.	67	$8.18K	0.00%
Zions Bancorporation, N.A.	39	$4.76K	0.00%
McElhenny Sheffield Capital Management, LLC	13	$1.59K	0.00%
Money Concepts Capital Corp	1	$122	0.00%
Coppell Advisory Solutions LLC	50	$90	0.00%
Coppell Advisory Solutions Corp.	50	$90	0.00%
Steward Financial Group LLC	1	$0	0.00%

Sold out (23)

Institutions that held Ascendis Pharma A/S at the end of Q3 2022 and filed for Q4 2022 without it.

Institutions that sold out of ASND in Q4 2022
Institution	Shares, Q3 2022	Value, Q3 2022
Logos Global Management LP	250,000	$25.8M
Vivo Capital, LLC	146,025	$15.1M
CIBC Asset Management Inc	129,064	$13.3M
Clear Street LLC	90,181	$9.31M
Octagon Capital Advisors LP	83,500	$8.62M
Berylson Capital Partners, LLC	51,000	$5.27M
Brookfield Asset Management Inc.	45,086	$4.66M
Alps Advisors Inc	30,416	$3.14M
EcoR1 Capital, LLC	27,208	$2.81M
Caption Management, LLC	24,472	$2.53M
HAP Trading, LLC	18,199	$1.88M
Squarepoint Ops LLC	17,329	$1.79M
Vanguard Group Inc	3,462	$357.0K
Cna Financial Corp	2,985	$308.0K
Dynamic Technology Lab Private Ltd	2,890	$299.0K
Guggenheim Capital LLC	2,571	$265.0K
OneAscent Wealth Management LLC	2,202	$227.0K
Leonteq Securities AG	600	$62.0K
Bourgeon Capital Management LLC	84	$9.00K
Whittier Trust Co	87	$9.00K
Brown Brothers Harriman & Co	80	$8.00K
Elequin Capital LP	76	$8.00K
Asset Dedication, LLC	2	$0

Not filed for Q4 2022 yet (3)

Institutions that held Ascendis Pharma A/S at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding ASND in Q3 2022 that haven't filed for Q4 2022
Institution	Shares, Q3 2022	Value, Q3 2022
Foresite Capital Management III, LLC	133,691	$13.8M
Wipfli Financial Advisors LLC,	511	$53.0K
FourThought Financial, LLC	491	$51.0K